Staphylococcus aureus News and Research

RSS

Staphylococcus aureus is a spherical bacterium (coccus) which on microscopic examination appears in pairs, short chains, or bunched, grape-like clusters. These organisms are Gram-positive. Some strains are capable of producing a highly heat-stable protein toxin that causes illness in humans.

Neem Biotech present biofilm disruptor at BIO Boston 2018, to minimise antimicrobial resistance

Neem Biotech, a Wales based pharmaceutical biotech working in the field of novel antimicrobial research and development will present details of the company’s approach to minimising antimicrobial resistance through biofilm disruption at BIO Boston 2018.

From Neem Biotech 7 Jun 2018

FDA files complaint against company marketing unapproved hand sanitizers

The U.S. Food and Drug Administration today filed a complaint against Innovative BioDefense, Inc. of Lake Forest, California, and Colette Cozean, the company's president and chief executive officer, to prohibit them from selling Zylast topical antiseptics with claims that they are effective against infection by pathogens such as norovirus, rotavirus, flu virus, Methicillin-Resistant Staphylococcus Aureus, and Ebola.

7 Jun 2018

Germ-fighting robot gives boost to hospital's infection control program

A germ-fighting robot that uses pulsed xenon ultraviolet (UV) light to sanitize rooms at Trinity Hospital is giving a boost to the hospital's infection control program.

5 Jun 2018

Tiny ultrasound-powered nanorobots could offer safe, efficient way to detoxify biological fluids

Engineers at the University of California San Diego have developed tiny ultrasound-powered robots that can swim through blood, removing harmful bacteria along with the toxins they produce. These proof-of-concept nanorobots could one day offer a safe and efficient way to detoxify and decontaminate biological fluids.

31 May 2018

Frequent MRSA surveillance could contain infection in newborns, study finds

The more often a hospital can check its newborns for deadly MRSA germs, the more likely it will be that they are contained, according to a new study.

23 May 2018

Drug-resistant staph infections found to be deadly, but less costly

Staph infections, whether MRSA (resistant to methicillin) or susceptible, are important and deadly. Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly less, a new national analysis shows.

15 May 2018

Scientists uncover new target for MRSA

Researchers at Michigan State University have identified why methicillin-resistant Staphylococcus aureus or MRSA is so resilient, a finding that could pave the way for potential new treatments.

15 May 2018

New study aims to turn MRSA’s strength against it

Antibiotic-resistant infections cause more than 30,000 deaths annually in the U.S. alone. The majority of those are caused by methicillin-resistant Staphylococcus aureus, more commonly known as MRSA, which can turn routine medical operations into near-death battles.

15 May 2018

Addressing Antimicrobial Resistance Through Industry

Antimicrobial resistance is currently one of the biggest health threats in the world. Gary Cohen and Steve Conly discuss the role of Becton, Dickinson & Co and other organizations in the private sector in combating the spread of resistance.

11 May 2018

New study shows MRSA is no more expensive to treat than MSSA

A new study from the Center for Disease Dynamics, Economics & Policy, with collaborators from Johns Hopkins University and University of Texas Southwestern Medical Center, found that infections caused by one of the most common drug resistant bacteria in the US--methicillin-resistant Staphylococcus aureus, known as MRSA--are no more expensive to treat than MSSA, the methicillin-susceptible version of the same bacteria.

10 May 2018

Researchers use CRISPR/Cas9 technique to turn off gene that regulates cholesterol levels in adult mice

Biomedical engineers at Duke University have used a CRISPR/Cas9 genetic engineering technique to turn off a gene that regulates cholesterol levels in adult mice, leading to reduced blood cholesterol levels and gene repression lasting for six months after a single treatment.

27 Apr 2018

Study shows nitric oxide inhibits S. aureus bacteria from transforming to its virulent form

According to the U.S. Centers for Disease Control and Prevention, about one in three humans carries Staphylococcus aureus, or "staph," in our noses, and 2 percent of us carry the dreaded methicillin-resistant (MRSA) strain that thwarts common antibiotics.

27 Apr 2018

NovaDigm Therapeutics initiates NDV-3A Phase 2a study for reduction of S. aureus in military trainees

NovaDigm Therapeutics, a company developing innovative immuno-therapeutics and preventative vaccines for fungal and bacterial infections, today announced the initiation of a Phase 2a study evaluating NDV-3A for the reduction of Staphylococcus aureus (S. aureus) colonization in a high-risk population of military trainees.

19 Apr 2018

Using the Microbiome to Predict the Risk of Cirrhosis-Associated Hospitalization

The microbiome is the collection of microorganisms that colonize the human body. Dr. Jasmohan Bajaj discusses the relationship between the microorganisms in the gut and cirrhosis, and how microbiome analysis can be used to predict the risk of cirrhosis-associated hospitalizations.

7 Apr 2018

Germs that are near impossible to kill are on the rise warns CDC

Antibiotic resistance is on the rise and how! The Centers for Disease Control and Prevention (CDC), this week (3rd April 2018), released a warning that these bacteria that are near impossible to kill with the available antibiotics are on the rise.

5 Apr 2018

Tackling Hand Hygiene Barriers in Healthcare

Hand hygiene is critical to preventing the spread of infection in hospitals. Current methods are outdated, and new technologies are expensive. Zoono's products offer an alternative to alcohol-based hand sanitizers that protect the skin's surface for longer.

28 Mar 2018

Staphylococcus aureus News and Research

Further Reading

Neem Biotech present biofilm disruptor at BIO Boston 2018, to minimise antimicrobial resistance

FDA files complaint against company marketing unapproved hand sanitizers

Germ-fighting robot gives boost to hospital's infection control program

Tiny ultrasound-powered nanorobots could offer safe, efficient way to detoxify biological fluids

Frequent MRSA surveillance could contain infection in newborns, study finds

Drug-resistant staph infections found to be deadly, but less costly

Scientists uncover new target for MRSA

New study aims to turn MRSA’s strength against it

Addressing Antimicrobial Resistance Through Industry

New study shows MRSA is no more expensive to treat than MSSA

Researchers use CRISPR/Cas9 technique to turn off gene that regulates cholesterol levels in adult mice

Study shows nitric oxide inhibits S. aureus bacteria from transforming to its virulent form

NovaDigm Therapeutics initiates NDV-3A Phase 2a study for reduction of S. aureus in military trainees

Using the Microbiome to Predict the Risk of Cirrhosis-Associated Hospitalization

Germs that are near impossible to kill are on the rise warns CDC

Tackling Hand Hygiene Barriers in Healthcare

Researchers characterize S. aureus gene involved in virulence and antibiotic resistance

Experts highlight urgent need to prevent infections in patients undergoing hemodialysis

Study uses ACEA Biosciences’ xCELLigence assay to monitor disruption of S. aureus biofilms

Research shows how interaction between nervous and immune systems occurs in lung infections

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News